Rocket Pharmaceuticals RCKT Balance Sheet (2012-2026)

NASDAQ RCKT
$2.48 +0.03 (+1.22%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Rocket Pharmaceuticals Quarterly Balance Sheet

Periods 52 quarters
Latest Jun 2026

Rocket Pharmaceuticals reported total assets of $423.10M and total liabilities of $54.27M for the quarter ended Jun 2026, up 0.5% year over year. This balance sheet covers 52 quarters of results from Dec 2012 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Dec2012 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
245.64M232.69M130.55M187.55M196.67M140.52M64.58M45.08M225.66M55.90M35.28M38.61M65.60M163.64M49.81M32.82M75.95M77.56M49.61M224.51M
Short-term InvestmentsInvestments (Current)
175.82M156.05M216.04M133.82M109.87M215.88M266.51M261.96M211.51M317.27M295.04M240.22M170.06M208.70M268.35M238.68M146.81M111.37M94.77M59.24M
Cash & Current Investments
421.50M388.70M346.60M321.40M306.50M356.39M360.00M307.00M437.20M407.50M330.30M278.80M235.70M372.30M318.20M271.50M222.80M188.90M144.40M283.70M
Receivables - OtherOther Receivables
0.50M1.00M0.50M
Current Deferred Tax AssetsCurrent Deferred Tax
-129.08M-133.09M
Prepaid Assets
3.61M3.32M7.26M4.40M4.60M7.67M6.95M5.03M9.69M5.05M14.85M13.90M6.09M5.85M6.33M5.66M4.92M3.81M5.45M5.80M
Current Assets
425.07M392.06M353.85M325.77M311.13M364.06M338.03M312.07M446.87M378.22M345.16M292.73M241.75M378.18M324.49M277.16M227.68M192.73M149.83M289.55M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
22.09M22.30M24.35M24.85M25.61M29.01M30.59M32.99M36.53M39.17M39.34M39.55M38.51M36.79M34.57M32.52M29.77M28.17M26.66M25.10M
Long-Term Investments
43.28M28.96M34.32M
Goodwill
30.82M30.82M30.82M30.82M30.82M39.20M39.20M39.20M39.20M39.20M39.20M39.20M39.20M39.20M39.20M39.20M39.20M39.20M39.20M39.20M
Intangibles
25.72M25.72M25.72M25.15M25.15M25.15M25.15M25.15M25.15M25.15M25.15M25.15M25.15M25.15M25.15M
Goodwill & Intangibles
30.82M30.82M30.82M30.82M30.82M64.92M64.92M64.92M64.35M64.35M64.35M64.35M64.35M64.35M64.35M64.35M64.35M64.35M64.35M64.35M
Long-Term Deferred Tax
-1.06M-1.06M
Other Non-Current Assets
1.79M1.80M1.80M1.80M1.81M1.95M1.80M1.90M1.91M1.91M1.90M1.84M1.87M1.89M1.88M1.88M1.88M1.82M1.82M1.82M
Non-Current Assets
105.17M104.96M106.30M106.08M106.13M187.75M176.72M149.71M151.90M188.12M154.28M153.69M151.93M149.52M146.57M143.82M140.35M137.72M135.58M133.55M
Assets
530.24M497.02M460.15M431.85M417.27M551.81M514.76M461.78M598.76M566.34M499.44M446.41M393.69M527.70M471.07M420.98M368.03M330.45M285.41M423.10M
Liabilities
Current Liabilities
Accounts Payables
22.01M19.62M20.03M21.84M27.82M36.66M28.61M31.35M30.62M45.79M30.09M34.73M37.13M37.83M32.44M40.51M28.26M27.29M21.54M28.34M
Notes Payables
Payables
22.01M19.62M20.03M21.84M27.82M36.66M28.61M31.35M30.62M45.79M30.09M34.73M37.13M37.83M32.44M40.51M28.26M27.29M21.54M28.34M
Accumulated Expenses
Other Accumulated Expenses
1.11M0.73M1.64M0.65M1.88M2.27M1.79M1.27M1.85M1.77M2.75M3.06M2.77M1.63M2.95M1.71M2.67M2.33M4.22M1.35M
Current Leases
1.68M1.69M1.70M1.71M1.72M1.74M1.75M1.76M1.77M1.79M1.81M1.83M1.84M1.86M1.87M1.88M1.90M1.91M1.93M1.94M
Current Taxes
8.62M
Current Deferred Tax LiabilityCurrent Deferred Tax
-7.83M-5.96M
Total Current Liabilities
24.49M22.17M22.57M24.29M30.18M39.17M31.21M34.35M33.48M48.51M32.96M37.59M39.98M40.68M35.31M43.40M31.17M30.21M24.47M31.32M
Non-Current Liabilities
Capital Leases
19.11M19.14M19.18M19.21M19.24M19.27M19.29M19.32M19.34M19.35M19.36M19.37M19.38M19.38M19.38M19.38M19.38M19.36M19.35M19.33M
Non-Current Debt
Convertible Debt
Preferred Stock Liabilities
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
21.41M21.93M
Operating Leases
0.89M0.91M0.72M0.61M0.49M1.09M0.20M3.07M2.99M2.97M3.71M3.57M3.41M3.26M3.10M2.93M2.76M2.60M2.49M2.49M
Other Non-Current Liabilities
0.09M0.08M0.07M0.05M0.04M2.60M1.88M2.07M1.87M2.94M1.91M1.25M1.14M1.14M1.14M1.06M1.06M1.06M1.06M1.13M
Total Non-Current Liabilities
44.49M42.22M42.47M44.11M49.92M59.53M54.01M56.74M55.81M70.83M56.03M60.53M62.78M63.33M57.79M65.71M53.30M52.17M46.31M53.14M
Total Liabilities
44.58M42.30M42.53M44.16M49.95M62.12M55.88M58.81M57.68M73.77M57.94M61.78M63.92M64.47M58.93M66.77M54.36M53.23M47.37M54.27M
Shareholder's Equity
Total Debt
Common Equity
485.66M454.72M417.62M387.70M367.31M489.69M458.88M402.97M541.09M492.57M441.50M384.64M329.77M463.23M412.14M354.21M313.67M277.22M238.04M368.83M
Liabilities and Shareholders Equity
530.24M497.02M460.15M431.85M417.27M551.81M514.76M461.78M598.76M566.34M499.44M446.41M393.69M527.70M471.07M420.98M368.03M330.45M285.41M423.10M
Treasury Stock
0.05M0.05M0.05M
Retained Earnings
-447.70M-491.91M-534.90M-589.30M-647.10M-713.78M-772.11M-837.81M-899.71M-959.37M-1,021.42M-1,091.07M-1,160.00M-1,218.12M-1,280.00M-1,350.00M-1,400.00M-1,441.24M-1,490.00M-1,370.00M
Preferred Shares
Treasury Shares
0.00M0.00M0.00M

Rocket Pharmaceuticals Balance Sheet API

Pull Rocket Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RCKT&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY